Members and Friends,
The New Year is nearly here! In this brief Newsletter, your Virginia Bio team simply wants to THANK YOU for allowing us to partner with you and support all the wonderful things you are doing for our life sciences ecosystem in the Commonwealth! It has been an action-packed first 5 months for me and our team, highlighted by an extremely successful 4th Annual Women Building Bio Conference, and several exciting Commercialization Luncheon keynotes from Donna Edmonds (CEO, Brainbox), Reinhardt Eberl (CEO, Anton Paar), David Alwood (CEO, FUJIFILM Wako Chemicals), and Dan Hathorn (Business Development Manager, ADS, Inc.). We look forward to continuing our work into the New Year to bring even more useful programing, and to help bring life saving innovations to our Commonwealth and the world.
Keep your Equity! Member Benefit of Note-New Monthly Call Reporting on Non-Dilutive Funding Opportunities! Augmenting the monthly GBG Report available to members listing these opportunities, our friends at G2G Consulting are going to provide monthly GBG Report Highlights Calls on the third Friday of the month at 10-10:30 am on their conference line: (202) 827-6334, no passcode needed. On this call members will hear: (1) overview of new funding opportunities; (2) key categories for funding; (3) new items of interest; (4) tips for the application process; and (5) answers to questions on non-dilutive funding. Please mark your calendars!
Virginia Bio Advocacy for the Industry: Two brief updates:
U.S. House of Representatives: Lower Drug Costs Now Act (H.R.3). Many of you have been following this piece of legislation, which would make sweeping changes to our larger private health care system by granting the government authority to set medicine prices in public and private markets that will have a detrimental impact on future medical innovation. This bill has passed the House and is awaiting a vote in the Senate, where it is expected to face major opposition and not pass. Virginia Bio joined the Virginia Chamber of Commerce, the Greater Richmond Urban Collective and the Virginia Asian Chamber of Commerce on an October 17 PhRMA We Work for Health letter to each member of the Virginia Congressional Delegation advocating against HR3.
Permanent Repeal of the Medical Device Tax. The pending compromise Federal spending bill passed December 17 in the House contains provisions for a complete repeal of the Medical Device Tax. It is now headed to the Senate where the spending bill is expected to pass, then to the President for signature, which will thus end the specter of this tax. Virginia Bio joined MDMA and 615 other life science organizations and companies, including the Advanced Medical Technology Association (AdvaMed) and the Medical Imaging & Technology Alliance (MITA), on a September 24 letter to Congressional leaders urging a permanent repeal of the medical device tax.
Upcoming Events. We look forward to seeing you at our next Virginia Bioscience Commercialization Luncheon in Richmond, January 9, 2020, where I will be providing a Virginia General Assembly 2020 preview. Come learn about issues being debated in the General Assembly that are critical to our industries. We will open the forum to welcome your policy concerns and ideas for how Commonwealth and local governments can stimulate research and commercialization. Virginia Bio will be stomping the General Assembly building all Session to represent you!
JPM 2020 is Here! The Virginia Reception returns to the San Francisco Clift Hotel on January 12, 2020 to kick off the 38th J.P. Morgan Healthcare Conference. The JPM Healthcare Conference is the largest healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Attendance at JPM 2020 is limited, so please be sure to mark your calendars and sign up here to reserve a free (for members) meeting room blocked time, available January 13-15.
Other events of note in 2020: We are also looking forward to attending the BIO Annual conference in San Diego, June 8-11; the BioHealth Captial Region Forum at AstraZenneca (Gaithersburg) April 15-16; and the 5th Annual Women Building Bio Conference in September. Please click here to keep apprised of all of Virginia Bio’s upcoming events.
Your Ideas. Virginia Bio wants to hear from you! Contact us at firstname.lastname@example.org, your ideas, comments, suggestions and advice regarding how Virginia Bio can best support you and our biotechnology ecosystem.
Happy Holidays, and we look forward to seeing you in the New Year!
John, Cassandra and Caron